Longitudinal Imaging Patterns and Corticosteroid Management in COVID-19 Patients with Pre-existing Interstitial Lung Disease: A 24-Month Cohort Analysis - Top-Institutions - MDSpire

Longitudinal Imaging Patterns and Corticosteroid Management in COVID-19 Patients with Pre-existing Interstitial Lung Disease: A 24-Month Cohort Analysis

  • By

  • Cheng Jiang

  • Sihao Cui

  • Shixuan Hou

  • Min Chen

  • Qiuyan Huang

  • Xiangyu Zhang

  • Sijia Li

  • Deqin Yang

  • Mengshu Cao

  • February 10, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    National Jewish Health
    National Jewish Health

    Denver, CO

    Key Differentiators

    • Pulmonology
    • Interstitial Lung Disease
    • COVID-19 Research

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Pulmonology
    • Interstitial Lung Disease
    • Imaging Research

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Pulmonology
    • Interstitial Lung Disease
    • Radiology

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Pulmonology
    • Interstitial Lung Disease
    • Infectious Diseases

  • #5

    Imperial College London
    Imperial College London

    London, N/A

    Key Differentiators

    • Pulmonology
    • Interstitial Lung Disease
    • Medical Imaging

Original Source(s)

Longitudinal Imaging Patterns and Corticosteroid Management in COVID-19 Patients with Pre-existing Interstitial Lung Disease: A 24-Month Cohort Analysis

  • by Cheng Jiang, Sihao Cui, Shixuan Hou, Min Chen, Qiuyan Huang, Xiangyu Zhang, Sijia Li, Deqin Yang, Mengshu Cao

  • February 10, 2026

Related Content

A machine learning-based classification model for interstitial lung disease in rheumatoid arthritis

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

MDA5-related juvenile dermatomyositis and interstitial lung disease: Transitioning from rapid progression to a quiescent state in three pediatric cases from South Africa, along with a literature review.